Rex Hermansen, MD
Article
High-Normal Potassium Levels Reduce Ventricular Arrhythmias and Related Adverse Outcomes in High-Risk Patients with ICDs
June 18, 2026
Mount Sinai Med-Lit Review Clinical question: Does actively increasing serum potassium to the high-normal range (4.5 to 5.0 mmol/L) reduce malignant ventricular arrhythmias, arrhythmia-related...
![1]()
News
Apixaban noninferior to low-molecular-weight heparin in cancer-associated VTE
December 6, 2021
Is oral apixaban as safe and effective as subcutaneous dalteparin in treating venous thromboembolism (VTE) in patients with underlying cancer?
